Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Lancet Oncol. 2020 Apr;21(4):519-530. doi: 10.1016/S1470-2045(19)30863-0. Epub 2020 Mar 12.
Lancet Oncol. 2020.
PMID: 32171426
Clinical Trial.
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up.
Piccart M, Procter M, Fumagalli D, de Azambuja E, Clark E, Ewer MS, Restuccia E, Jerusalem G, Dent S, Reaby L, Bonnefoi H, Krop I, Liu TW, Pieńkowski T, Toi M, Wilcken N, Andersson M, Im YH, Tseng LM, Lueck HJ, Colleoni M, Monturus E, Sicoe M, Guillaume S, Bines J, Gelber RD, Viale G, Thomssen C; APHINITY Steering Committee and Investigators.
Piccart M, et al. Among authors: monturus e.
J Clin Oncol. 2021 May 1;39(13):1448-1457. doi: 10.1200/JCO.20.01204. Epub 2021 Feb 4.
J Clin Oncol. 2021.
PMID: 33539215
Free article.
Clinical Trial.
Item in Clipboard
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study.
Kuemmel S, Tondini CA, Abraham J, Nowecki Z, Itrych B, Hitre E, Karaszewska B, Juárez-Ramiro A, Morales-Vásquez F, Pérez-García JM, Cardona-Huerta S, Monturus E, Sequi M, Restuccia E, Benyunes M, Martín M.
Kuemmel S, et al. Among authors: monturus e.
Breast Cancer Res Treat. 2021 Jun;187(2):467-476. doi: 10.1007/s10549-021-06145-3. Epub 2021 Mar 21.
Breast Cancer Res Treat. 2021.
PMID: 33748921
Free PMC article.
Clinical Trial.
Item in Clipboard
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer.
Hurvitz SA, Bachelot T, Bianchini G, Harbeck N, Loi S, Park YH, Prat A, Gilham L, Boulet T, Gochitashvili N, Monturus E, Lambertini C, Nyawira B, Knott A, Restuccia E, Schmid P.
Hurvitz SA, et al. Among authors: monturus e.
Future Oncol. 2022 Oct;18(32):3563-3572. doi: 10.2217/fon-2022-0485. Epub 2022 Nov 16.
Future Oncol. 2022.
PMID: 36382554
Free article.
Item in Clipboard
DNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation.
Fernández-Nestosa MJ, Monturus E, Sánchez Z, Torres FS, Fernández AF, Fraga MF, Hernández P, Schvartzman JB, Krimer DB.
Fernández-Nestosa MJ, et al. Among authors: monturus e.
Springerplus. 2013 Aug 21;2:392. doi: 10.1186/2193-1801-2-392. eCollection 2013.
Springerplus. 2013.
PMID: 24010046
Free PMC article.
Item in Clipboard
Topoisomerase 2 is dispensable for the replication and segregation of small yeast artificial chromosomes (YACs).
Cebrián J, Monturus E, Martínez-Robles ML, Hernández P, Krimer DB, Schvartzman JB.
Cebrián J, et al. Among authors: monturus e.
PLoS One. 2014 Aug 12;9(8):e104995. doi: 10.1371/journal.pone.0104995. eCollection 2014.
PLoS One. 2014.
PMID: 25115861
Free PMC article.
Item in Clipboard
Cite
Cite